Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-050127

Options or other derivatives

  • CMO acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
AYCARDI-FONSECA ERNESTO CMO 2019-09-16 Grant or award · Stock Option (Right to Buy) +65,000 65,000 D
Loading xslF345X03/doc4.xml…